[The clinical relevance of effect sizes].
The question of whether differences between therapeutic alternatives are judged as clinically relevant is of major importance. However, formally based solutions are rare and of limited practical use. The present state of the debate is presented. It is argued that the basis of the relevance debate is a value-based multi-dimensional decision as to which therapeutic group differences will be judged clinically relevant.
Windeler
Jürgen
J
Medizinischer Dienst des Spitzenverbandes Bund der Krankenkassen e.V., Essen. j.windeler@mds-ev.de
Thomas
Stefanie
S
D003661:Decision Support Techniques; D006801:Humans; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D015203:Reproducibility of Results